IBKR
Interactive Brokers Group Inc
$72.73-6.61%
Setup
No setup
Buy Zone
$72.51-$76.14
Sector
Capital Markets
Industry
Capital Markets
38
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
IBKR chart
Loading chart…
ADX
Weak or Absent19.5Long Term
Up ↑Intermediate Term
Up ↑Short Term
Up ↑Overall Quality38
RS Rating
36
relative strength
Fundamentals
68
Solid fund-Q
Volume Demand
68
+161% vs avg
Technical Setup
25
2/8 checks
Industry/Theme
91
Capital Markets
Trade Plan
Avoid
Entry
$72.51
Entry Zone
$72.51-$76.14
Stop / Risk
$66.71
RS Rating
36
Volume confirmed
No
Targets
$87.01 / $90.64
Breakout · IBD Setup
1 ✓ 7 ✗
Entry $72.51–$76.14Stop $66.71Target $87.01 / $90.64
Market regimeRange
Quality38
RS Rating36
Above 50-MA-16.22%
Above 200-MA-12.4%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
38
MarketRange
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q68 · Solid
StatusAvoid
Stock Data
52-Week Range59 – 99
Price % Chg YTD13.09%
Price % Chg 4wk-17.11%
50-Day Avg Vol4.3 Mil
P/E Ratio29.4
Market Cap$35B
SectorFinancial
IndustryCapital Markets
Company Fundamentals
EPS % Chg (Qtr)17.15%
Sales % Chg (Qtr)16.19%
EPS Growth 5y29.67%
Sales Growth 5y33.08%
Annual ROE20.79%
Gross Margin95.97%
Operating Margin86.51%
Net Margin10.02%
Debt / Equity5.67
Setup levels
Current price
$72.73
Pivot
$72.51
Distance to buy
-26.3%
52-week range
58.95-98.75
Trigger evidence
No active trigger evidence available.
Financial health checks
4/5
Return on equity above 15%
ROE 20.79%
Net margin above 10%
Net margin 10.02%
EPS growing quarter on quarter
EPS q/q 17.15%
Sales growing quarter on quarter
Sales q/q 16.19%
Debt to equity below 1.0
D/E 5.67
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE20.79%
vs sector +5.4%
Net margin10.02%
vs sector -10.1%
Gross margin95.97%
vs sector +20.3%
EPS growth q/q17.15%
vs sector +0.0%
Sales growth q/q16.19%
vs sector +9.6%
Debt / equity5.67
vs sector +2.92
Business quality
68
GradeSolid
EPS rating56
P/E29.4
Market cap$35B
IndustryCapital Markets
Technical checks
Über 50-MA
Fail
Über 200-MA
Fail
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Fail
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-11-05
Trigger date
—
Days on list
1
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.